Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$317,361,279
-$41,491,663 QoQ
Shares Held
2,511,962
-2.4% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#64
of 2,266 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pictet Asset Management Holding SA holds $3,393,842,702 across 13 Drug Manufacturers - General names. GILD ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
754,985 | $905,551,734 | |
| 2 | AZN |
Astrazeneca PLC
|
2,937,510 | $557,010,646 | |
| 3 | JNJ |
Johnson & Johnson
|
1,853,258 | $470,671,934 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
2,511,962 | $317,361,279 | |
| 5 | AMGN |
Amgen Inc
|
872,311 | $315,881,259 | |
| 6 | ABBV |
AbbVie Inc.
|
909,328 | $228,823,297 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,451,505 | $186,518,392 | |
| 8 | BIIB |
Biogen Inc.
|
851,819 | $184,044,013 |
All Filings in GILD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $317,361,279 | 2,511,962 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $358,852,942 | 2,574,822 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $289,238,528 | 2,356,514 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $297,857,400 | 2,683,400 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $292,377,383 | 2,637,119 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $356,057,811 | 3,177,669 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $296,752,849 | 3,212,654 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $357,272,673 | 4,261,363 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $177,117,332 | 2,581,509 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $309,153,529 | 4,220,526 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $407,755,490 | 5,033,397 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $398,086,450 | 5,312,069 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||